07-07-2024, 10:20 PM
Twenty-five people in the US out of around 30,000 have been diagnosed with secondary cancer after receiving the treatment for a separate cancer.
CAR-T - which was approved in 2017 - takes immune cells from the body and engineers them to attack tumors before being infused back into the blood.
But the way it is delivered may disrupt cell DNA and lead to other cancers, which is a small risk with all so-called gene therapies.
https://www.msn.com/en-sg/health/other/r...d=msedgntp&pc=U531&cvid=ae9cb12c5f8342aab08fe60cd0b0186e&ei=17
CAR-T - which was approved in 2017 - takes immune cells from the body and engineers them to attack tumors before being infused back into the blood.
But the way it is delivered may disrupt cell DNA and lead to other cancers, which is a small risk with all so-called gene therapies.
https://www.msn.com/en-sg/health/other/r...d=msedgntp&pc=U531&cvid=ae9cb12c5f8342aab08fe60cd0b0186e&ei=17